Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Inhibrx Biosciences, Inc. (INBX), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
-11.06
P/B ratioShare price divided by book value per share.
-29.04
P/S ratioMarket value divided by annual revenue.
1445.13
PEG ratioP/E divided by the earnings growth rate.
-0.59
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.
-10.94
EV / RevenueEnterprise value against annual revenue.
1428.13
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.
-10.42%
Free cash flow yieldFree cash flow as a percentage of market value.
-9.13%
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
0.00%
Operating marginRevenue left after operating costs.
-13500.00%
Net marginRevenue left after every cost, including tax and interest.
-14000.00%
Return on equityProfit as a percentage of shareholders’ equity.
-563.89%
Return on assetsProfit as a percentage of total assets.
-89.60%
Return on capital employedOperating profit against the capital the business uses.
-101.31%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
5.07
Quick ratioThe same, excluding inventory.
5.07
Cash ratioCash alone against current liabilities.
3.65
Debt to equityTotal borrowings against shareholders’ equity.
-0.10
Debt to assetsTotal borrowings against total assets.
0.73
Interest coverageHow many times operating profit covers the interest bill.
-8.21
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
$-9.04
Book value per shareShareholders’ equity divided by shares outstanding.
$0.00
Shares outstandingShares currently issued.
0
Market capitalisationShare price times shares outstanding.
$1.37B
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$1.42B
EmployeesReported headcount.
156
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
0.00%
Inhibrx Biosciences, Inc. (INBX) statistics — frequently asked questions
What is Inhibrx Biosciences, Inc.'s P/E ratio?
Inhibrx Biosciences, Inc. (INBX) trades on a price-to-earnings ratio of -11.06. A negative P/E means the company reported a loss, so the ratio is not a meaningful valuation measure.
What is Inhibrx Biosciences, Inc.'s return on equity?
Inhibrx Biosciences, Inc. (INBX) reports a return on equity of -563.89%, meaning it generated that much profit for every dollar of shareholders' equity.
How much debt does Inhibrx Biosciences, Inc. carry?
Inhibrx Biosciences, Inc. (INBX) has a debt-to-equity ratio of -0.10, which compares total borrowings with shareholders' equity.
What is Inhibrx Biosciences, Inc.'s profit margin?
Inhibrx Biosciences, Inc. (INBX) keeps -14000.00% of revenue as net profit after every cost, including tax and interest.